BACKGROUND/ AIM: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease affecting upper and lower motor neurons, causing progressive atrophy of muscles, hypertonia, and paralysis. This study aimed to evaluate the current evidence and effectiveness of ultrasound in investigating nerve cross-sectional area (CSA) of peripheral nerves, vagus and cervical roots in those with ALS compared with healthy controls and to pool the CSA measurements. METHODS: A systematic search was conducted on Cochrane, Clarivate Web of Science, PubMed, Scopus, and Embase for the mesh terms nerve, ultrasonography, and amyotrophic lateral sclerosis. A quality assessment was performed using the New-Ottawa scale. In addition, a double-arm meta-analysis using Review Manager 5 software version 5.4 was performed. RESULTS: From the seventeen studies included in this review, the overall mean difference showed that individuals with ALS had a significantly smaller CSA in comparison to healthy controls for median, ulnar, C6 root, and phrenic nerves. However, no significant difference in the CSA was found in radial, vagal, sural, and tibial nerves. DISCUSSION: This study confirmed results of some of the included studies regards the anatomic sites, where nerve atrophy in ALS could be detected to potentially support the diagnosis of ALS. However, we recommend further large, prospective studies to assess the diagnostic value of these anatomical sites for the diagnosis of ALS. CONCLUSIONS: Our findings confirmed specific anatomic sites to differentiate ALS patients from healthy controls through ultrasound. However, these findings cannot be used to confirm the ALS diagnosis, but rather assist in differentiating it from other diagnoses. TRIAL REGISTRATION: Retrospectively registered on July 30th 2024 in PROSPERO (PROSPERO (york.ac.uk)) with ID574702.

Department of Neurology RWTH Aachen University Pauwels Street 30 52074 Aachen Germany

Department of Neurology Wake Forest School of Medicine Winston Salem North Carolina USA

Department of Psychiatry and Psychotherapy 3 University of Ulm Ulm Germany

Department of Psychiatry School of Medicine and Health Sciences Carl von Ossietzky University Oldenburg Oldenburg Germany

Department of Public Health Theodor Bilharz Research Institute Giza Egypt

Faculty of medicine Alexandria University Alexandria Egypt

Faculty of Medicine Assiut University Assiut Egypt

Faculty of medicine Cairo University Cairo Egypt

Faculty of Medicine Mansoura University Mansoura Egypt

Faculty of Medicine Masaryk University Brno Czech Republic

Faculty of Medicine October 6 University Giza Egypt

Faculty of Medicine Suez Canal University Ismailia Egypt

Faculty of Pharmacy Clinical Department Alexandria University Alexandria Egypt

Faculty of pharmacy University Grenoble Alpes La tronche France

Microbiology Department Faculty of Science Tanta University Tanta Egypt

Neurology Department University of Greifswald Greifswald Germany

Zobrazit více v PubMed

Ilieva, H., Vullaganti, M., & Kwan, J. (2023). Advances in molecular pathology, diagnosis, and treatment of amyotrophic lateral sclerosis. BMJ (Clinical Research ed), 383, e075037–e075037. 10.1136/bmj-2023-075037 PubMed PMC

Oskarsson, B., Gendron, T. F., & Staff, N. P. (2018). Amyotrophic Lateral Sclerosis: An Update for 2018. Mayo Clinic Proceedings. 93(11):1617–1628. 10.1016/j.mayocp.2018.04.007 PubMed

Talbott, E. O., Malek, A. M., & Lacomis, D. (2016). The epidemiology of amyotrophic lateral sclerosis (pp. 225–238). Elsevier. PubMed

Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000). El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 1(5), 293–299. 10.1080/146608200300079536 PubMed

de Carvalho, M., Dengler, R., Eisen, A., et al. (2008). Electrodiagnostic criteria for diagnosis of ALS. Clinical Neurophysiology, 119(3), 497–503. 10.1016/j.clinph.2007.09.143 PubMed

Shefner, J. M., Al-Chalabi, A., Baker, M. R., Cui, L. Y., de Carvalho, M., Eisen, A., Grosskreutz, J., Hardiman, O., Henderson, R., Matamala, J. M., Mitsumoto, H., Paulus, W., Simon, N., Swash, M., Talbot, K., Turner, M. R., Ugawa, Y., van den Berg, L. H., Verdugo, R., Vucic, S., Kaji, R., Burke, D., & Kiernan, M. C. (2020). A proposal for new diagnostic criteria for ALS. Clinical Neurophysiology, 131(8), 1975–1978. Epub 2020 Apr 19. PMID: 32387049. PubMed

Genge, A., & Chio, A. (2022). The future of ALS diagnosis and staging: Where do we go from here? Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 24(3–4), 165–174. 10.1080/21678421.2022.2150555 PubMed

Hobson-Webb, L. D., Simmons, Z., ULTRASOUND IN THE DIAGNOSIS, & AND MONITORING OF AMYOTROPHIC LATERAL SCLEROSIS. (2019). A REVIEW. Muscle & Nerve, 60(2), 114–123. 10.1002/mus.26487 PubMed

Nodera, H., Takamatsu, N., Shimatani, Y., et al. (2014). Thinning of cervical nerve roots and peripheral nerves in ALS as measured by sonography. Clinical Neurophysiology, 125(9), 1906–1911. 10.1016/j.clinph.2014.01.033 PubMed

Schreiber, S., Dannhardt-Stieger, V., Henkel, D., et al. (2016). Quantifying disease progression in amyotrophic lateral sclerosis using peripheral nerve sonography. Muscle & Nerve, 54(3), 391–397. 10.1002/mus.25066 PubMed

Suratos, C. T., Takamatsu, N., Yamazaki, H., et al. (2021). Utility of phrenic nerve ultrasound in amyotrophic lateral sclerosis. Acta Neurol Belg, 121(1), 225–230. 10.1007/s13760-020-01531-y PubMed PMC

Cartwright, M. S., Walker, F. O., Griffin, L. P., & Caress, J. B. (2011). Peripheral nerve and muscle ultrasound in amyotrophic lateral sclerosis. Muscle & Nerve, 44(3), 346–351. 10.1002/mus.22035 PubMed PMC

Page, M. J., McKenzie, J., Bossuyt, P., et al. (2020). Updating guidance for reporting systematic reviews: Development of the PRISMA 2020 statement. Center for Open Science. PubMed

Cumpston, M., Li, T., Page, M. J., et al. (2019). Updated guidance for trusted systematic reviews: A new edition of the Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Database of Systematic Reviews, 10(10), ED000142–ED000142. 10.1002/14651858.ED000142 PubMed PMC

Stang, A. (2010). Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. European Journal of Epidemiology, 25(9), 603–605. 10.1007/s10654-010-9491-z PubMed

Ma, L. L., Wang, Y. Y., Yang, Z. H., Huang, D., Weng, H., & Zeng, X. T. (2020). Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: What are they and which is better? Mil Med Res, 7(1), 7. 10.1186/s40779-020-00238-8 PubMed PMC

WebPlotDigitizer, A. R. (Version 4.6) 2023. http://arohatgi.info/WebPlotDigitizer

DerSimonian, R., & Laird, N. (1986). Meta-analysis in clinical trials. Controlled Clinical Trials, 7(3):177–188. 10.1016/0197-2456(86)90046-2 PubMed

Wallace, B. C., Dahabreh, I. J., Trikalinos, T. A., Lau, J., Trow, P., Schmid, C. H. (2012). Closing the Gap between Methodologists and End-Users: R as a Computational Back-End. Journal of Statistical Software, 49(5). 10.18637/jss.v049.i05

Deilami, P., Ghourchian, S., Haghi Ashtiani, B. (2020). Correlations Between Median Nerve Sonography and Conduction Study Results and Functional Scales in Amyotrophic Lateral Sclerosis. Acta Medica Iranica. 10.18502/acta.v57i11.3264

Grimm, A., Décard, B. F., Athanasopoulou, I., Schweikert, K., Sinnreich, M., & Axer, H. (2015). Nerve ultrasound for differentiation between amyotrophic lateral sclerosis and multifocal motor neuropathy. Journal of Neurology, 262(4), 870–880. 10.1007/s00415-015-7648-0 PubMed

Holzapfel, K., & Naumann, M. (2020). Ultrasound Detection of Vagus nerve atrophy in Bulbar Amyotrophic lateral sclerosis. Journal of Neuroimaging, 30(6), 762–765. 10.1111/jon.12761 PubMed

Martínez-Payá, J. J., Ríos-Díaz, J., del Baño-Aledo, M. E., et al. (2022). The cross-sectional area of the median nerve: An independent prognostic biomarker in amyotrophic lateral sclerosis. Neurología. 10.1016/j.nrl.2022.01.008 PubMed

Mohamed, R. Z. A., Salem, H. H., Sakr, H. M. E. S., Afifi, H-E-M., Elsadek, A. M., & Fahmy, N. A. (2021). Role of neuro-sonography of peripheral nerves as a diagnostic and a differentiation tool of amyotrophic lateral sclerosis. The Egyptian Journal of Neurology Psychiatry and Neurosurgery, 57(1). 10.1186/s41983-021-00389-y

Mori, A., Nodera, H., Takamatsu, N., et al. (2015). Focal nerve enlargement is not the cause for increased distal motor latency in ALS: Sonographic evaluation. Clinical Neurophysiology, 126(8), 1632–1637. 10.1016/j.clinph.2014.10.152 PubMed

Noto, Y. I., Garg, N., Li, T., et al. (2018). Comparison of cross-sectional areas and distal‐proximal nerve ratios in amyotrophic lateral sclerosis. Muscle & Nerve, 58(6), 777–783. 10.1002/mus.26301 PubMed

Papadopoulou, M., Bakola, E., Papapostolou, A., et al. (2022). Autonomic dysfunction in amyotrophic lateral sclerosis: A neurophysiological and neurosonology study. Journal of Neuroimaging, 32(4), 710–719. 10.1111/jon.12993 PubMed

Ríos-Díaz, J., del Baño-Aledo, M. E., Tembl-Ferrairó, J. I., Chumillas, M. J., Vázquez-Costa, J. F., & Martínez-Payá, J. J. (2019). Quantitative neuromuscular ultrasound analysis as biomarkers in amyotrophic lateral sclerosis. European Radiology, 29(8), 4266–4275. 10.1007/s00330-018-5943-8 PubMed

Schreiber, S., Schreiber, F., Debska-Vielhaber, G., et al. (2018). Differential involvement of forearm muscles in ALS does not relate to sonographic structural nerve alterations. Clinical Neurophysiology, 129(7), 1438–1443. 10.1016/j.clinph.2018.04.610 PubMed

Schreiber, S., Schreiber, F., Garz, C., et al. (2019). Toward in vivo determination of peripheral nervous system immune activity in amyotrophic lateral sclerosis. Muscle & Nerve, 59(5), 567–576. 10.1002/mus.26444 PubMed

Schreiber, S., Vielhaber, S., Schreiber, F., & Cartwright, M. S. (2020). Peripheral nerve imaging in amyotrophic lateral sclerosis. Clinical Neurophysiology, 131(9), 2315–2326. 10.1016/j.clinph.2020.03.026 PubMed

Weise, D., Menze, I., Metelmann, M. C. F., Woost, T. B., Classen, J., & Otto Pelz, J. (2021). Multimodal assessment of autonomic dysfunction in amyotrophic lateral sclerosis. European Journal of Neurology, 29(3), 715–723. 10.1111/ene.15177 PubMed

Schreiber, S., Abdulla, S., Debska-Vielhaber, G., et al. (2015). Peripheral nerve ultrasound in amyotrophic lateral sclerosis phenotypes. Muscle & Nerve, 51(5), 669–675. 10.1002/mus.24431 PubMed

Preston, D. C., & Shapiro, B. E. (2013). Clinical–electrophysiologic correlations (pp. 249–266). Elsevier.

Daube, J. R. (2000). Electrodiagnostic studies in amyotrophic lateral sclerosis and other motor neuron disorders. Muscle & Nerve, 23(10), 1488–1502. PubMed

Kiernan, M. C., Vucic, S., Cheah, B. C., et al. (2011). Amyotrophic lateral sclerosis. The Lancet, 377(9769), 942–955. 10.1016/s0140-6736(10)61156-7 PubMed

Hildebrand, A., Schreiber, F., Weber, L., Arndt, P., Garz, C., Petri, S., Prudlo, J., Meuth, S. G., Waerzeggers, Y., Henneicke, S., Vielhaber, S., & Schreiber, S. (2023). Peripheral nerve ultrasound for the differentiation between ALS, Inflammatory, and Hereditary polyneuropathies. Medicina (Kaunas), 59(7), 1192. 10.3390/medicina59071192PMID: 37512004; PMCID: PMC10383275. PubMed PMC